pig
believ
one
import
sourc
emerg
human
swine
influenza
virus
swiv
influenza
viru
conserv
peptid
potenti
elicit
crossprotect
immun
respons
without
help
potent
adjuv
deliveri
system
poorli
immunogen
biodegrad
polylacticcoglycol
acid
plga
nanoparticl
plganp
base
vaccin
deliveri
system
enhanc
crosspresent
antigen
profession
antigen
present
cell
studi
noroviru
p
particl
contain
swiv
extracellular
domain
matrix
protein
chimera
highli
conserv
two
peptid
pandem
classic
human
influenza
virus
entrap
plganp
influenza
antibodyfre
pig
vaccin
plganp
peptid
cocktail
vaccin
twice
without
adjuv
mycobacterium
vacca
whole
cell
lysat
intranas
mist
vaccin
pig
challeng
virul
heterolog
zoonot
swiv
one
week
later
euthan
lung
sampl
analyz
specif
immun
respons
viral
load
clinic
pig
vaccin
plganp
peptid
vaccin
fever
flu
symptom
replic
challeng
swiv
undetect
bronchoalveolar
lavag
fluid
immunolog
plganp
peptid
vaccin
without
adjuv
significantli
increas
frequenc
antigenspecif
secret
cell
respons
lung
lymphocyt
despit
boost
antibodi
respons
preand
postchalleng
summari
data
indic
nanoparticlemedi
deliveri
conserv
influenza
peptid
induc
viru
specif
cell
respons
lung
reduc
challeng
heterolog
viru
load
airway
pig
swine
influenza
highli
contagi
acut
respiratori
viral
diseas
pig
caus
subtyp
influenza
viru
iav
diseas
respons
signific
econom
loss
swine
industri
pig
also
play
critic
role
emerg
new
strain
influenza
virus
act
mix
vessel
current
swine
flu
vaccin
strain
specif
fail
induc
crossprotect
genet
variant
flu
virus
moreov
intramuscularli
deliv
flu
vaccin
induc
poor
mucos
iga
antibodi
cell
respons
highli
conserv
influenza
viral
protein
across
iav
subtyp
matrix
nucleocapsid
np
stalk
domain
hemagglutinin
ha
promis
new
gener
flu
vaccin
platform
includ
use
highli
conserv
peptid
vaccin
formul
recent
develop
biotechnolog
tool
made
larg
scale
product
antigen
peptid
highli
feasibl
low
cost
attempt
made
develop
iav
peptid
vaccin
coexpress
conserv
peptid
protein
ectodomain
hepat
b
capsid
protein
also
use
cocktail
conserv
b
cell
peptid
due
lack
identifi
effect
vaccin
deliveri
potent
adjuv
system
peptid
base
vaccin
candid
unsuccess
induc
robust
respons
pig
moreov
intramuscularli
vaccin
anim
mucos
immun
system
weakli
activ
recent
chimer
construct
express
surfac
loop
noroviru
p
particl
shown
produc
high
level
antibodi
respons
protect
mice
lethal
challeng
pig
also
induc
specif
immun
respons
fail
provid
protect
diseas
unpublish
data
potent
vaccin
deliveri
adjuv
system
essenti
enhanc
immunogen
peptid
vaccin
one
endeavor
st
centuri
deliveri
vaccin
drug
biocompat
biodegrad
polym
base
nano
microparticl
plga
poli
lacticcoglycol
acid
nontox
fda
european
medicin
agenc
approv
polym
wide
use
vehicl
drug
vaccin
deliveri
properti
plga
made
ideal
entrap
even
solubl
vaccin
ag
nanoparticl
np
nm
elicit
strong
immun
respons
plganp
entrap
peptid
ag
protect
enzymat
ionic
degrad
vivo
uptaken
antigen
present
cell
apc
particul
antigen
readili
taken
mucos
cell
apc
nasalassoci
lymphoid
tissu
intranas
vaccin
anim
enhanc
antigen
specif
secret
cell
respons
product
highaffin
neutral
antibodi
pig
benefit
plga
base
intranas
vaccin
deliveri
system
inactiv
porcin
reproduct
respiratori
syndrom
viru
prrsv
pig
hepat
b
ag
rodent
demonstr
studi
cocktail
conserv
two
b
cell
peptid
human
iav
swiv
entrap
plganp
character
vaccin
properti
vitro
efficaci
candid
vaccin
evalu
virul
heterolog
zoonot
swiv
challeng
intranas
vaccin
pig
coadminist
without
adjuv
vacca
wcl
result
indic
induct
peptid
specif
cell
respons
reduct
lung
viral
load
clinic
flu
symptom
specif
antibodi
respons
boost
preand
postchalleng
np
base
peptid
vaccin
pig
dulbecco
minimum
essenti
medium
dmem
lonza
supplement
fetal
bovin
serum
atlanta
biolog
co
viru
infect
dmem
contain
tpck
chloromethyl
keton
trypsin
without
fetal
bovin
serum
use
prepar
nanoparticl
polylacticcoglycol
acid
plga
mw
lakeshor
biomateri
al
polyvinyl
alcohol
mw
sigmaaldrich
dicholoro
methan
acro
organ
use
micro
bca
bicinchonin
acid
protein
assay
kit
pierc
use
estim
peptid
concentr
cytotox
lymphocyt
specif
peptid
specif
np
nsdtvgwsw
pa
ateyimkgvi
pandem
viru
use
hlaia
present
antigen
peptid
cell
commonli
express
five
swine
breed
indic
valuabl
sla
allel
surviv
longterm
evolutionari
select
two
peptid
use
studi
nsengtcypgdfidyeelreqlssvssfekfeif
domain
human
asouth
strain
genbank
npengtcypgyfadyeel
reqlssvssferfeif
np
protein
chosen
human
influenza
strain
anew
four
peptid
evalu
vaccin
candid
swiv
challeng
pig
peptid
slltevetptrsewecrcsdssd
swiv
consensu
sequenc
express
chimera
construct
use
pparticl
express
vector
contain
pdomain
sequenc
noroviru
genogroup
ii
cluster
describ
previous
chimera
studi
earlier
mice
prepar
plganp
entrap
conserv
iav
peptid
plganp
entrap
four
conserv
peptid
ha
np
pa
prepar
use
doubl
emuls
method
wateroilwat
describ
previous
briefli
mg
four
peptid
total
mg
suspend
pb
mix
pva
wv
wv
sucros
wv
mg
oh
emulsifi
mg
plga
dissolv
ml
dichloromethan
use
probe
sonic
mm
sec
power
ice
result
waterinoil
wo
primari
emuls
ml
wv
polyvinyl
alcohol
pva
contain
polaxm
ad
divid
equal
two
tube
emuls
sonic
sec
power
ice
secondari
emuls
stir
overnight
allow
evapor
organ
solvent
result
plganp
wash
thrice
cold
steril
milli
q
water
centrifug
rpm
min
final
plganp
resuspend
sucros
milli
q
water
lyophil
similarli
mg
chimera
suspend
pb
entrap
plganp
peptid
releas
profil
peptid
entrap
plganp
determin
vitro
analysi
period
week
describ
previous
briefli
mg
plga
nppeptid
suspend
ml
steril
pb
centrifug
g
min
supernat
collect
estim
burst
releas
min
reconstitut
pellet
contain
nppeptid
resuspend
everi
time
point
ml
pb
harvest
supernat
collect
hr
reconstitut
day
store
last
day
nppeptid
hydrolyz
use
buffer
contain
sd
n
naoh
recov
remain
entrap
peptid
peptid
concentr
sampl
estim
use
micro
bca
protein
assay
kit
peptid
releas
day
amount
releas
hydrolysi
togeth
consid
estim
total
peptid
amount
cumul
releas
express
percentag
amount
entrap
peptid
plganp
determin
describ
previous
briefli
freezedri
np
mg
dissolv
ml
freshli
prepar
buffer
sd
n
naoh
incub
hr
constant
stir
mixtur
centrifug
g
min
supernat
collect
total
protein
concentr
quantifi
use
micro
bca
protein
assay
kit
shape
surfac
morpholog
plganp
determin
scan
electron
microscopi
hitachi
n
describ
previous
briefli
freezedri
particl
dispers
pb
concentr
mgml
spread
adhes
stub
dri
coat
goldpalladium
vacuum
use
ion
coater
coat
specimen
examin
microscop
kv
size
distribut
plganp
determin
use
nicomp
particl
sizer
particl
size
system
fl
zeta
potenti
plganp
determin
zeta
pal
brookhaven
instrument
corp
holtsvil
ny
usa
describ
previous
vacca
atcc
grown
endotoxin
free
medium
accord
atcc
instruct
whole
cell
lysat
wcl
prepar
previous
describ
briefli
live
vacca
cultur
harvest
wash
twice
steril
endotoxin
free
pb
ph
suspend
pb
contain
mm
edta
proteinas
inhibitor
dnase
rnase
bacteria
disrupt
endotoxin
free
condit
use
bead
beater
approxim
breakag
observ
lysat
centrifug
x
g
min
pellet
unbroken
cell
insolubl
cell
wall
compon
collect
supernat
wcl
contain
solubl
compon
filtersteril
use
filter
protein
content
endotoxin
level
vacca
wcl
quantifi
bca
protein
assay
kit
lyophil
aliquot
mg
protein
store
use
studi
influenza
specif
antibodi
commonli
found
major
commerci
pig
henc
caesarean
deliv
colostrumdepriv
week
old
n
convent
larg
whiteduroc
crossbr
pig
use
pig
randomli
divid
five
group
n
pig
per
group
group
mock
mok
group
mockchalleng
mkc
group
peptid
pep
group
nanoparticleentrap
peptid
adjuv
npa
group
nanoparticleentrap
peptid
npp
tabl
vaccin
dose
pep
npp
npa
four
peptid
chimera
includ
vaccin
inocul
twice
day
interv
mist
use
multidos
aerosol
devic
develop
exclus
use
pig
prima
tech
neogen
corpor
usa
adjuv
vacca
wcl
mg
per
pig
mix
plganp
entrap
peptid
inocul
pig
group
challeng
day
booster
swiv
tcid
volum
deliv
intranas
intratrach
rout
pig
euthan
day
postchalleng
dpc
mockinocul
pig
euthan
separ
prior
kill
infect
anim
pig
maintain
vaccin
challeng
euthan
facil
accord
guidelin
protocol
approv
institut
biosafeti
committe
institut
anim
care
use
committe
swiv
challeng
pig
observ
daili
clinic
sign
influenza
dpc
rectal
temperatur
record
daili
begin
day
challeng
necropsi
lung
examin
gross
patholog
chang
score
viru
induc
consolid
describ
previous
swiv
titer
bal
fluid
collect
dpc
euthan
pig
quantifi
qrtpcr
previous
describ
briefli
total
rna
extract
bal
fluid
use
rna
multisampl
kit
ambion
accord
protocol
provid
manufactur
autom
express
magnet
particl
processor
life
technolog
use
sampl
process
qpcr
perform
estim
viral
rna
load
sampl
swiv
rna
load
test
sampl
calcul
use
standard
curv
yaxi
viru
concentr
tcid
xaxi
ct
valu
replic
challeng
swiv
bal
fluid
quantifi
indirect
immunofluoresc
assay
ifa
describ
previous
briefli
mdck
cell
monolay
cultur
plate
treat
tenfold
serial
dilut
bal
fluid
dilut
serum
free
dmem
supplement
tpck
trypsin
hr
cell
wash
fix
aceton
water
air
dri
plate
immunostain
use
influenza
nucleoprotein
specif
mab
calbioreag
ca
follow
goat
antimous
igg
alexa
conjug
secondari
antibodi
invitrogen
plate
wash
treat
pbsglycerol
immunofluoresc
evalu
use
invert
fluoresc
microscop
olympu
center
valley
pa
swiv
specif
iga
igg
isotyp
antibodi
bal
plasma
sampl
analyz
describ
previous
briefli
plate
coat
pretitr
quantiti
challeng
swiv
tcid
per
well
carbonatebicarbon
buffer
ph
overnight
plate
wash
treat
block
buffer
bsa
tween
pb
hr
rt
bal
fluid
sampl
dilut
ad
first
well
subsequ
twofold
serial
dilut
incub
hr
rt
bound
viru
specif
isotyp
antibodi
detect
use
affin
purifi
goat
antipig
iga
secondari
antibodi
conjug
hrp
bethyl
laboratori
inc
tx
final
plate
develop
use
chromogen
tmb
tetramethylbenzidin
kpl
reaction
stop
use
phosphor
acid
plate
read
use
spectra
max
micropl
reader
nm
bal
fluid
end
point
titer
determin
base
highest
dilut
sampl
measur
od
valu
greater
mean
od
valu
seven
swiv
neg
pig
bal
fluid
sampl
plu
two
standard
deviat
respect
dilut
use
similarli
swiv
specif
igg
antibodi
end
point
titer
bal
fluid
plasma
determin
elisa
peptid
specif
iga
level
also
determin
coat
peptid
concentr
ml
od
valu
compar
experiment
group
swiv
specif
hemagglutin
inhibit
hi
titer
pig
bal
fluid
plasma
sampl
determin
accord
recommend
world
organ
anim
health
oie
world
organ
anim
health
swiv
specif
neutral
antibodi
hemagglutin
inhibit
titer
plasma
bal
fluid
analyz
describ
previous
determin
viru
neutral
vn
antibodi
titer
plasma
bal
fluid
sampl
heat
inactiv
min
twofold
dilut
incub
equal
volum
tcid
swiv
per
well
hr
suspens
transfer
microtit
plate
contain
confluent
monolay
mdck
cell
incub
hr
follow
incub
antiswiv
nucleoprotein
specif
mab
cal
bioreag
ca
conjug
antimous
igg
hl
secondari
antibodi
mount
glycerol
pb
ratio
vn
titer
reciproc
highest
dilut
test
sampl
inhibit
greater
viru
infect
peptid
specif
recal
lymphocyt
respons
assay
describ
previous
modif
briefli
lung
mononuclear
cell
lmnc
pig
dpc
isol
enzymat
digest
lung
tissu
describ
previous
five
million
lmnc
restimul
individu
peptid
swiv
multipl
infect
moi
phytohaemagglutinin
hr
enrich
rpmi
erpmi
fb
gentamicin
ampicillin
mm
hepe
mm
lglutamin
mm
nonessenti
amino
acid
mm
sodium
pyruv
nm
brefeldin
sigma
ad
last
hr
incub
lmnc
treat
without
indic
stimul
surfac
immunostain
cell
fix
paraformaldehyd
permeabil
cellpermeabil
buffer
deioniz
water
pb
without
ca
mg
formaldehyd
solut
saponin
overnight
cell
wash
stain
fluorochromeconjug
antipig
clone
isotyp
control
mab
bd
bioscienc
saponin
contain
fluorescenceactiv
cellsort
fac
buffer
immunostain
cell
acquir
use
fac
aria
ii
bd
bioscienc
flow
cytomet
analyz
use
flowjo
tree
star
ashland
usa
softwar
specif
cell
popul
frequenc
present
percent
total
lymphocyt
cultur
supernat
stimul
lmnc
swiv
describ
harvest
centrifug
well
lmnc
cultur
plate
min
rpm
subject
elisa
describ
previous
background
cytokin
level
pig
group
subtract
specif
stimul
studi
carri
strict
accord
recommend
public
health
servic
polici
unit
state
depart
agricultur
regul
nation
research
council
guid
care
use
laboratori
anim
feder
anim
scienc
societi
guid
care
use
agricultur
anim
agricultur
research
teach
relev
institut
state
feder
regul
polici
regard
anim
care
use
ohio
state
univers
protocol
approv
committe
well
tissu
cultur
plate
stimul
lmnc
immunostain
analyz
flow
cytometri
previous
describ
briefli
lmnc
first
surfacelabel
pig
lymphocyt
specif
purifi
fluorochrom
biotin
conjug
mab
clone
clone
clone
southernbiotech
follow
treatment
fluorochrom
label
streptavidin
antimous
isotyp
specif
antibodi
intracellular
stain
bd
bioscienc
san
jose
ca
usa
ethic
anim
experi
ohio
state
univers
protocol
number
pig
maintain
sampl
collect
euthan
effort
made
minim
suffer
pig
data
express
mean
pig
standard
error
mean
sem
statist
analys
perform
use
one
way
analysi
varianc
anova
follow
posthoc
tukey
test
use
graphpad
instat
prism
softwar
version
establish
variat
among
mkc
pep
npp
npa
pig
group
statist
signific
assess
p
p
p
plga
particul
vaccin
deliveri
system
optimum
antigen
load
effici
charg
stabil
size
np
import
entrap
pool
four
peptid
separ
plganp
use
similar
procedur
vitro
character
peptid
entrap
np
show
compar
result
data
shown
entrap
effici
np
scan
electron
microscopi
sem
imag
np
reveal
spheric
particl
fig
size
distribut
profil
np
determin
dynam
light
scatter
techniqu
nm
major
np
around
nm
fig
surfac
charg
particl
mv
averag
valu
ten
run
measur
zeta
potenti
analysi
vitro
protein
releas
profil
npentrap
suspend
pb
overtim
quantifi
physiolog
condit
plganp
contain
vaccin
cargo
carri
small
quantiti
surfac
anchor
ag
rapidli
releas
upon
reconstitut
pb
min
call
burst
releas
entrap
ag
np
releas
period
week
observ
burst
releas
cumul
releas
includ
burs
releas
hr
day
total
releas
period
week
fig
thu
result
indic
plganp
releas
entrap
gradual
support
principl
depoteffect
provid
plganp
vivo
condit
sinc
pig
vaccin
challeng
via
nasal
rout
quantifi
influenza
ag
specif
cell
respons
lung
pig
use
lung
mononuclear
cell
lmnc
day
necropsi
isol
lmnc
either
unstimul
stimul
swiv
individu
peptid
analyz
frequenc
activ
lymphocyt
subset
repres
graph
depict
gate
pattern
restimul
porcin
lymphocyt
subset
secret
belong
swiv
infect
pig
shown
fig
porcin
immun
system
uniqu
abund
popul
doubl
posit
cell
subset
combin
thelper
memori
cytotox
cell
properti
result
detect
viru
peptid
specif
increas
frequenc
cell
lmnc
npp
vaccin
pig
compar
vaccin
formul
receiv
anim
fig
data
indic
influenza
ag
specif
activ
doubl
posit
cell
subset
lung
npp
vaccin
pig
pig
thelper
cell
identifi
base
express
combin
phenotyp
marker
similarli
marker
bear
cell
either
cytotox
cell
ctl
cell
express
cell
exclus
ctl
frequenc
thelper
cell
cell
lmnc
significantli
higher
npp
vaccin
pig
irrespect
cell
unstimul
stimul
viral
ag
peptid
fig
data
indic
presenc
activ
cell
subset
npp
vaccin
pig
continu
secret
cultur
ex
vivo
determin
influenza
ag
specif
recal
cell
respons
exclus
npp
vaccin
pig
three
cell
subset
npp
pig
group
plot
separ
fig
white
dot
line
show
figur
cell
subset
separ
specif
recal
cell
respons
control
c
unstimul
cell
fig
result
detect
presenc
increas
recal
cell
subset
swiv
peptid
stimul
lmnc
fig
st
panel
similarli
increas
recal
thelper
cell
popul
specif
peptid
fig
nd
panel
recal
specif
cell
respons
viru
peptid
fig
rd
panel
npp
vaccin
pig
detect
data
analysi
reveal
nanoparticl
entrap
conserv
influenza
peptid
induc
peptid
specif
cell
respons
pig
addit
supernat
harvest
cultur
lmnc
restimul
swiv
significantli
higher
level
secret
npp
compar
peptidesand
mockvaccin
pig
group
fig
quantifi
humor
immun
respons
vaccin
pig
perform
igg
antibodi
analysi
plasma
sampl
collect
day
prechalleng
dpc
use
pretitr
amount
swiv
swiv
protein
elisa
result
show
low
level
specif
antibodi
respons
data
statist
signific
among
vaccin
pig
group
fig
even
postchalleng
plasma
bal
fluid
sampl
vaccin
pig
collect
dpc
viru
specif
iga
igg
antibodi
hemagglutin
inhibit
hi
viru
neutral
vn
antibodi
titer
low
data
significantli
differ
among
experiment
pig
group
fig
thu
studi
indic
antibodi
respons
npp
npa
vaccin
pig
prechalleng
weak
absent
detect
antibodi
respons
postchalleng
induc
challeng
viru
result
suggest
need
use
addit
b
cell
antigen
peptid
inactiv
viru
gate
pattern
lymphocyt
pig
infect
swiv
restimul
ex
vivo
viru
day
immunostain
use
fluorochrom
conjug
pig
specif
marker
intracellular
identifi
frequenc
cell
shown
lung
mnc
lmnc
isol
day
necropsi
experiment
pig
either
unstimul
control
c
stimul
swiv
v
conserv
peptid
peptid
day
immunostain
cell
gate
cell
subset
describ
b
c
cell
e
delin
swiv
specif
cell
respons
npp
vaccin
pig
three
activ
lymphocyt
subset
lmnc
npp
vaccin
pig
either
unstimul
control
c
stimul
swiv
indic
peptid
shown
white
dot
line
drawn
across
cell
subset
separ
ag
specif
recal
cell
respons
control
unstimul
cell
npp
vaccin
pig
f
secret
cultur
supernat
viru
restimul
lmnc
vaccin
swiv
challeng
pig
analyz
elisa
background
cytokin
level
pig
group
subtract
specif
stimul
bar
indic
averag
frequenc
indic
cell
subset
cytokin
pig
sem
asterisk
denot
statist
signific
differ
p
p
p
indic
two
pig
group
determin
one
way
anova
follow
tukey
posthoc
test
signific
indic
pig
group
mock
unentrap
peptid
vaccin
virul
swiv
challeng
pig
rectal
temperatur
higher
dpc
compar
mock
anim
fig
pig
fever
anorex
letharg
initi
day
viral
challeng
similarli
challeng
npp
npa
vaccin
pig
group
suffer
hyperthermia
fig
associ
bodi
temperatur
viral
load
measur
viral
rna
copi
bal
fluid
observ
compar
rna
load
among
viruschalleng
pig
group
fig
replic
swiv
detect
mkc
pep
pig
group
undetect
npp
npa
vaccin
anim
fig
assay
repeat
three
time
confirm
live
swiv
titer
bal
fluid
sampl
nasal
swab
collect
dpc
show
detect
replic
viru
viru
challeng
pig
group
data
shown
summari
clinic
sign
flu
replic
detect
lung
viral
load
detect
swiv
challeng
control
mck
pep
plganp
peptid
npp
npa
vaccin
pig
group
control
influenza
pig
human
challeng
due
continu
genet
chang
viral
surfac
protein
therefor
enhanc
influenza
viru
specif
immun
respons
highli
conserv
antigen
epitop
import
achiev
increas
breadth
protect
immun
henc
elicit
strong
specif
respons
influenza
entrap
highli
conserv
peptid
plganp
inocul
intranas
form
mist
pig
effici
reach
mucos
induct
site
respiratori
tract
result
demonstr
significantli
reduc
detect
infecti
challeng
viru
airway
npp
npa
vaccin
pig
associ
augment
antigenspecif
cell
respons
lung
lymphocyt
npp
inocul
anim
amount
four
peptid
entrap
nppeptid
vaccin
assum
anoth
independ
studi
individu
peptid
entrap
plga
np
compar
level
entrap
effici
addit
result
ex
vivo
restimul
lmnc
four
individu
peptid
elicit
compar
peptid
specif
cell
respons
npp
vaccin
pig
studi
mice
demonstr
intranas
administr
chimera
induc
high
level
specif
antibodi
conserv
peptid
elicit
antibodi
respons
pig
fail
reduc
flu
symptom
solubl
antigen
peptid
poorli
immunogen
entrap
np
elicit
strong
immun
respons
pulmonari
immun
respons
vari
vaccin
particl
size
surfac
charg
particl
nm
readili
phagocyt
dendrit
cell
cell
mucos
site
consist
size
candid
nppeptid
vaccin
approxim
nm
plganp
entrap
ag
stabl
week
facilit
activ
matur
apc
mechan
induct
increas
breadth
protect
respons
np
base
vaccin
deliveri
system
mediat
effici
intern
particul
ag
follow
process
crosspresent
entrap
ag
dendrit
cell
macrophag
cell
shown
specif
use
plga
np
deliveri
system
mediat
abil
disrupt
phagosom
releas
cargo
cytosol
mhc
class
load
base
data
heighten
peptidespecif
doubl
posit
cell
respons
lmnc
npp
pig
group
expect
dendrit
cell
macrophag
lung
pig
would
uptaken
effici
crosspres
plganp
deliv
peptid
ag
cell
pig
vaccin
fusion
protein
without
np
deliveri
system
fail
protect
anim
challeng
viru
induc
flu
symptom
swiv
titer
bal
fluid
dpc
detect
b
viral
rna
load
qrtpcr
c
replic
infecti
viru
load
use
mdck
cell
immunofluoresc
assay
ratio
indic
bar
repres
number
pig
posit
viru
contribut
data
anim
viral
titer
express
tissu
cultur
infect
dose
tcid
ml
bal
fluid
data
point
bar
repres
averag
valu
pig
sem
asterisk
denot
statist
signific
differ
p
mkc
npp
npa
pig
group
determin
one
way
anova
follow
tukey
posthoc
test
pig
signific
upregul
activ
doubl
posit
cell
associ
protect
respons
classic
swine
fever
aujeszki
diseas
prr
virus
particular
studi
npp
npa
vaccin
pig
elicit
antigenspecif
increas
activ
secret
doubl
posit
cell
respons
lung
interestingli
complet
clearanc
detect
infecti
challeng
viru
observ
airway
npp
npa
vaccin
anim
despit
compar
low
level
humor
respons
data
suggest
critic
role
play
np
entrap
peptid
deliveri
system
pig
well
role
adjuv
vacca
wcl
possibl
skew
respons
npp
toward
balanc
state
need
investig
earlier
shown
strong
viru
specif
antibodi
respons
pig
vaccin
intranas
use
plganp
entrap
prrsv
potent
adjuv
tb
wcl
elicit
strong
balanc
respons
place
adjuv
tb
wcl
use
nonpathogen
mycobacterium
vacca
deriv
wcl
vacca
compar
biochem
cellular
compon
tb
also
shown
possess
potent
adjuv
effect
rodent
vacca
wcl
entrap
plganp
greater
adjuv
effect
solubl
compar
np
entrap
tb
wcl
intranas
vaccin
pig
observ
overal
studi
suggest
vacca
wcl
potent
adjuv
npp
vaccin
pig
indic
need
includ
addit
highli
antigen
b
cell
peptid
inactiv
swiv
entrap
np
coadminist
potent
adjuv
boost
specif
antibodi
respons
pig
conclus
studi
pig
first
time
demonstr
influenza
conserv
peptid
cocktail
entrap
biodegrad
nanoparticl
deliv
intranas
mist
induc
epitop
specif
cell
respons
despit
boost
antibodi
respons
therefor
futur
studi
focus
includ
addit
highli
antigen
influenza
viru
b
cell
peptid
potent
adjuv
enhanc
specif
mucos
system
antibodi
respons
nanoparticl
flu
vaccin
candid
import
biodegrad
nanoparticl
vaccin
deliveri
platform
translat
valu
improv
crossprotect
immun
genet
variant
influenza
virus
